Similar articles for PMID: 19436720

Year	Number of Results
2006	1
2007	7
2008	10
2009	16
2010	20
2011	16
2012	8
2013	13
2014	4
2015	3
2016	8
2017	9
2018	7
2019	3
2022	2
2024	0

1

Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors.

Xie L, Li J, Xie L, Bourne PE. Xie L, et al. PLoS Comput Biol. 2009 May;5(5):e1000387. doi: 10.1371/journal.pcbi.1000387. Epub 2009 May 15. PLoS Comput Biol. 2009. PMID: 19436720 Free PMC article.

2

Identification of a novel, non-tetrahydroquinoline variant of the cholesteryl ester transfer protein (CETP) inhibitor torcetrapib, with improved aqueous solubility.

Kalgutkar AS, Frederick KS, Hatch HL, Ambler CM, Perry DA, Garigipati RS, Chang GC, Lefker BA, Clark RW, Morehouse LA, Francone O, Hu X. Kalgutkar AS, et al. Xenobiotica. 2014 Jul;44(7):591-605. doi: 10.3109/00498254.2013.874611. Epub 2013 Dec 31. Xenobiotica. 2014. PMID: 24380613

3

Effects of CP-532,623 and torcetrapib, cholesteryl ester transfer protein inhibitors, on arterial blood pressure.

Blasi E, Bamberger M, Knight D, Engwall M, Wolk R, Winter S, Betts A, John-Baptiste A, Keiser J. Blasi E, et al. J Cardiovasc Pharmacol. 2009 Jun;53(6):507-16. doi: 10.1097/FJC.0b013e3181a8184c. J Cardiovasc Pharmacol. 2009. PMID: 19455053 Clinical Trial.

4

Binding profiles of cholesterol ester transfer protein with current inhibitors: a look at mechanism and drawback.

Yang Z, Cao Y, Hao D, Yuan X, Zhang L, Zhang S. Yang Z, et al. J Biomol Struct Dyn. 2018 Aug;36(10):2567-2580. doi: 10.1080/07391102.2017.1363661. Epub 2017 Aug 20. J Biomol Struct Dyn. 2018. PMID: 28777919

5

Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach.

Fan S, Geng Q, Pan Z, Li X, Tie L, Pan Y, Li X. Fan S, et al. BMC Syst Biol. 2012 Dec 10;6:152. doi: 10.1186/1752-0509-6-152. BMC Syst Biol. 2012. PMID: 23228038 Free PMC article.

6

HDL metabolism and CETP inhibition.

Barkowski RS, Frishman WH. Barkowski RS, et al. Cardiol Rev. 2008 May-Jun;16(3):154-62. doi: 10.1097/CRD.0b013e31816a3b60. Cardiol Rev. 2008. PMID: 18414186

7

Mechanism of Inhibition of Cholesteryl Ester Transfer Protein by Small Molecule Inhibitors.

Chirasani VR, Sankar R, Senapati S. Chirasani VR, et al. J Phys Chem B. 2016 Aug 25;120(33):8254-63. doi: 10.1021/acs.jpcb.6b01928. Epub 2016 May 4. J Phys Chem B. 2016. PMID: 27111423

8

Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week.

Armitage J, Holmes MV, Preiss D. Armitage J, et al. J Am Coll Cardiol. 2019 Feb 5;73(4):477-487. doi: 10.1016/j.jacc.2018.10.072. J Am Coll Cardiol. 2019. PMID: 30704580 Free PMC article. Review.

9

Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.

Vergeer M, Bots ML, van Leuven SI, Basart DC, Sijbrands EJ, Evans GW, Grobbee DE, Visseren FL, Stalenhoef AF, Stroes ES, Kastelein JJ. Vergeer M, et al. Circulation. 2008 Dec 9;118(24):2515-22. doi: 10.1161/CIRCULATIONAHA.108.772665. Epub 2008 Nov 24. Circulation. 2008. PMID: 19029469 Clinical Trial.

10

Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.

Yamashita S, Ruscica M, Macchi C, Corsini A, Matsuzawa Y, Sirtori CR. Yamashita S, et al. Atherosclerosis. 2018 Nov;278:286-298. doi: 10.1016/j.atherosclerosis.2018.09.035. Epub 2018 Oct 1. Atherosclerosis. 2018. PMID: 30347344 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year